{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:42:21Z","timestamp":1791322941919,"version":"4.3.1"},"reference-count":34,"publisher":"Impact Journals, LLC","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,4,4]]},"DOI":"10.18632\/oncotarget.15328","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T19:17:50Z","timestamp":1487186270000},"page":"23539-23550","source":"Crossref","is-referenced-by-count":33,"title":["Progression of motor deficits in glioma-bearing mice: impact of CNF1 therapy at symptomatic stages"],"prefix":"10.18632","volume":"8","author":[{"given":"Eleonora","family":"Vannini","sequence":"first","affiliation":[{"name":"Institute of Neuroscience, National Research Council (CNR), Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Maltese","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience, National Research Council (CNR), Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Olimpico","sequence":"additional","affiliation":[{"name":"BioSNS laboratory, Scuola Normale Superiore di Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Fabbri","sequence":"additional","affiliation":[{"name":"Istituto Superiore di Sanit\u00e0, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Costa","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience, National Research Council (CNR), Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Caleo","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience, National Research Council (CNR), Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Baroncelli","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience, National Research Council (CNR), Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,2,15]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.radonc.2007.10.008","article-title":"High grade glioma: imaging combined with pathological grade defines management and predicts prognosis","volume":"85","author":"Pohl","year":"2007","journal-title":"Radiother Oncol"},{"key":"2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1748-717X-6-2","article-title":"Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: analysis of single-agent and combined modality approaches","volume":"6","author":"Gutin","year":"2011","journal-title":"Radiat Oncol"},{"key":"3","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1158\/1078-0432.CCR-11-0120","article-title":"The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma","volume":"17","author":"Friedman","year":"2011","journal-title":"Clin Cancer Res"},{"key":"4","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/cncr.29798","article-title":"Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas","volume":"122","author":"Wen","year":"2016","journal-title":"Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrn2652","article-title":"Tests to assess motor phenotype in mice: a user's guide","volume":"10","author":"Dunnett","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/42743","article-title":"Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine","volume":"387","author":"Boquet","year":"1997","journal-title":"Nature"},{"key":"7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/toxins2010116","article-title":"Cytotoxic Necrotizing Factors (CNFs)-A Growing Toxin Family","volume":"2","author":"Schmidt","year":"2010","journal-title":"Toxins"},{"key":"8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/1471-2407-14-449","article-title":"The bacterial protein toxin, cytotoxic necrotizing factor 1 (CNF1) provides long-term survival in a murine glioma model","volume":"14","author":"Costa","year":"2014","journal-title":"BMC Cancer"},{"key":"9","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/neuonc\/now114","article-title":"Electrophysiology of glioma: a Rho GTPase-activating protein reduces tumor growth and spares neuron structure and function","volume":"18","author":"Caleo","year":"2016","journal-title":"Neuro Oncol"},{"key":"10","first-page":"227","article-title":"The Murine GL261 Glioma Experimental Model to Assess Novel Brain Tumor Treatments","author":"David","year":"2009","journal-title":"CNS Cancer"},{"key":"11","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/cercor\/bhq159","article-title":"The organization of the forelimb representation of the C57BL\/6 mouse motor cortex as defined by intracortical microstimulation and cytoarchitecture","volume":"21","author":"Jones","year":"2011","journal-title":"Cereb Cortex"},{"key":"12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1215\/15228517-2007-016","article-title":"Incidence of gliomas by anatomic location","volume":"9","author":"Auvinen","year":"2007","journal-title":"Neuro Oncol"},{"key":"13","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/1545968314545174","article-title":"Quantitative kinematic characterization of reaching impairments in mice after a stroke","volume":"29","author":"Micera","year":"2015","journal-title":"Neurorehabil Neural Repair"},{"key":"14","doi-asserted-by":"crossref","first-page":"13669","DOI":"10.1074\/jbc.273.22.13669","article-title":"The Rho-deamidating cytotoxic necrotizing factor 1 from Escherichia coli possesses transglutaminase activity: cysteine 866 and histidine 881 are essential for enzyme activity","volume":"273","author":"Aktories","year":"1998","journal-title":"J Biol Chem"},{"key":"15","doi-asserted-by":"crossref","first-page":"15163","DOI":"10.1523\/JNEUROSCI.2617-11.2011","article-title":"Activation of Rho GTPases triggers structural remodeling and functional plasticity in the adult rat visual cortex","volume":"31","author":"Caleo","year":"2011","journal-title":"J Neurosci"},{"key":"16","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1523\/JNEUROSCI.3353-13.2014","article-title":"The relationship between PSD-95 clustering and spine stability in vivo","volume":"34","author":"Holtmaat","year":"2014","journal-title":"J Neurosci"},{"key":"17","first-page":"222","article-title":"Defective herpes simplex virus vectors expressing thymidine kinase for the treatment of malignant glioma","volume":"4","author":"Rabkin","year":"1997","journal-title":"Cancer Gene Ther"},{"key":"18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1006\/cimm.1997.1140","article-title":"Treatment of murine gliomas by adoptive transfer of ex vivo activated tumor-draining lymph node cells","volume":"178","author":"Shu","year":"1997","journal-title":"Cell Immunol"},{"key":"19","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00006123-199910000-00028","article-title":"Prolongation of survival of mice with glioma treated with semiallogeneic fibroblasts secreting interleukin-2","volume":"45","author":"Cohen","year":"1999","journal-title":"Neurosurgery"},{"key":"20","first-page":"230","article-title":"Flavopiridol inhibits the growth of GL261 gliomas in vivo: implications for malignant glioma therapy","volume":"3","author":"Zagzag","year":"2004","journal-title":"Cell Cycle"},{"key":"21","first-page":"5514","article-title":"Therapeutic efficacy of OX-40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth","volume":"60","author":"Shu","year":"2000","journal-title":"Cancer Res"},{"key":"22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/09593985.2012.734010","article-title":"Brain meningioma in a patient with complaints of low back pain and leg weakness","volume":"29","author":"Di Stasi","year":"2013","journal-title":"Physiother Theory Pract"},{"key":"23","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/brain\/aws041","article-title":"Motor deficits correlate with resting state motor network connectivity in patients with brain tumours","volume":"135","author":"McKhann","year":"2012","journal-title":"Brain"},{"key":"24","first-page":"37823","article-title":"Health-related quality of life in patients with glioblastoma: a randomised controlled trial","volume":"6","author":"Bottomley","year":"2016","journal-title":"Sci Rep"},{"key":"25","doi-asserted-by":"crossref","first-page":"e34115","DOI":"10.1371\/journal.pone.0034115","article-title":"CNF1 improves astrocytic ability to support neuronal growth and differentiation in vitro","volume":"7","author":"Fiorentini","year":"2012","journal-title":"PLoS One"},{"key":"26","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.diii.2014.08.001","article-title":"Diffuse low-grade gliomas and neuroplasticity","volume":"95","author":"Duffau","year":"2014","journal-title":"Diagn Interv Imaging"},{"key":"27","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/brain\/awv394","article-title":"Mapping neuroplastic potential in brain-damaged patients","volume":"139","author":"Duffau","year":"2016","journal-title":"Brain"},{"key":"28","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1349-7006.2006.00208.x","article-title":"Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy","volume":"97","author":"S\u00e1fr\u00e1ny","year":"2006","journal-title":"Cancer Sci"},{"key":"29","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.1038\/ncomms7623","article-title":"Enriched environment reduces glioma growth through immune and non-immune mechanisms in mice","volume":"6","author":"Limatola","year":"2015","journal-title":"Nat Commun"},{"key":"30","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1021\/acsnano.5b07375","article-title":"A Combined Approach Employing Chlorotoxin-Nanovectors and Low Dose Radiation To Reach Infiltrating Tumor Niches in Glioblastoma","volume":"10","author":"Matteoli","year":"2016","journal-title":"ACS Nano"},{"key":"31","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.biopsych.2009.12.022","article-title":"Early Environmental Enrichment Moderates the Behavioral and Synaptic Phenotype of MeCP2 Null Mice","volume":"67","author":"Pizzorusso","year":"2010","journal-title":"Biol Psychiatry"},{"key":"32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bbr.2013.05.062","article-title":"Post-stroke protection from maladaptive effects of learning with the non-paretic forelimb by bimanual home cage experience in C57BL\/6 mice","volume":"252","author":"Jones","year":"2013","journal-title":"Behav Brain Res"},{"key":"33","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/1545968313506520","article-title":"A robotic system for quantitative assessment and poststroke training of forelimb retraction in mice","volume":"28","author":"Caleo","year":"2014","journal-title":"Neurorehabil Neural Repair"},{"key":"34","article-title":"Reducing GABAA-mediated inhibition improves forelimb motor function after focal cortical stroke in mice","author":"Caleo","year":"2016","journal-title":"Sci Rep"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15328","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T18:12:49Z","timestamp":1589134369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,15]]},"references-count":34,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2017,4,4]]}},"alternative-id":["15328","28212563"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.15328","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,15]]}}}